Literature DB >> 7919312

Recurrence of HIV-related tuberculosis in an endemic area may be due to relapse or reinfection.

P Godfrey-Faussett1, W Githui, B Batchelor, R Brindle, J Paul, M Hawken, S Gathua, J Odhiambo, S Ojoo, P Nunn.   

Abstract

SETTING: Two Research Clinics within Nairobi, Kenya, one in the Infectious Diseases Hospital, the national referral centre for tuberculosis, and one in a community based project in Pumwani district, and the Bacterial Molecular Genetics Unit at the London School of Hygiene and Tropical Medicine.
OBJECTIVE: To determine whether recurrence of tuberculosis after 'adequate' treatment was due to reinfection with a different isolate of Mycobacterium tuberculosis or to relapse of the original infection.
DESIGN: A retrospective comparison by DNA fingerprinting of sets of isolates of M. tuberculosis from patients with recurrence of tuberculosis and in whom isolates from the original episode had been stored was made. Five patients with recurrence of tuberculosis two to nineteen months after adequate treatment and documented clearance of disease were studied.
RESULTS: In one patient, fingerprints of the isolates of M. tuberculosis from the recurrence were quite different to those from the original episode; in the other four, the fingerprints were identical.
CONCLUSION: Reinfection rather than relapse was the cause of recurrence in at least one patient. The high 'relapse' rates seen in HIV-related tuberculosis in Africa may in part be due to increased susceptibility to reinfection and not to treatment failure.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7919312     DOI: 10.1016/0962-8479(94)90008-6

Source DB:  PubMed          Journal:  Tuber Lung Dis        ISSN: 0962-8479


  6 in total

1.  Efficacy of an unsupervised 8-month rifampicin-containing regimen for the treatment of pulmonary tuberculosis in HIV-infected adults. Uganda-Case Western Reserve University Research Collaboration.

Authors:  J L Johnson; A Okwera; P Nsubuga; J G Nakibali; C C Whalen; D Hom; M D Cave; Z H Yang; R D Mugerwa; J J Ellner
Journal:  Int J Tuberc Lung Dis       Date:  2000-11       Impact factor: 2.373

Review 2.  Methodological and Clinical Aspects of the Molecular Epidemiology of Mycobacterium tuberculosis and Other Mycobacteria.

Authors:  Tomasz Jagielski; Alina Minias; Jakko van Ingen; Nalin Rastogi; Anna Brzostek; Anna Żaczek; Jarosław Dziadek
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

3.  Pulmonary tuberculosis in Harare, Zimbabwe: analysis by spoligotyping.

Authors:  R S Heyderman; M Goyal; P Roberts; S Ushewokunze; S Zizhou; B G Marshall; R Makombe; J D Van Embden; P R Mason; R J Shaw
Journal:  Thorax       Date:  1998-05       Impact factor: 9.139

4.  Buruli ulcer recurrence, Benin.

Authors:  Martine Debacker; Julia Aguiar; Christian Steunou; Claude Zinsou; Wayne M Meyers; Françoise Portaels
Journal:  Emerg Infect Dis       Date:  2005-04       Impact factor: 6.883

5.  Recurrent TB: relapse or reinfection? The effect of HIV in a general population cohort in Malawi.

Authors:  Amelia C Crampin; J Nimrod Mwaungulu; Frank D Mwaungulu; D Totah Mwafulirwa; Kondwani Munthali; Sian Floyd; Paul Em Fine; Judith R Glynn
Journal:  AIDS       Date:  2010-01-28       Impact factor: 4.177

6.  The study recurrent tuberculosis and exogenous reinfection, Shanghai, China.

Authors:  Guomiao Shen; Zhen Xue; Xin Shen; Bin Sun; Xiaohong Gui; Mei Shen; Jian Mei; Qian Gao
Journal:  Emerg Infect Dis       Date:  2006-11       Impact factor: 6.883

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.